{"id":5991,"date":"2022-11-23T22:32:18","date_gmt":"2022-11-23T21:32:18","guid":{"rendered":"https:\/\/p664637.webspaceconfig.de\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/"},"modified":"2026-07-22T13:27:19","modified_gmt":"2026-07-22T11:27:19","slug":"immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb","status":"publish","type":"izb-biotech-news","link":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/","title":{"rendered":"Immunic hosted Multiple Sclerosis R&#038;D Webcast, presenting updates on its lead asset, vidofludimus calcium"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>The company discussed the MS treatment landscape and recent scientific findings with key opinion leaders.<\/p>\n","protected":false},"featured_media":5989,"parent":0,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-5991","izb-biotech-news","type-izb-biotech-news","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"acf_migration":{"izb_related_company":"4556"},"wpml_migration":{"language_code":"en","source_language_code":"de","trid":"29675"},"yoast_migration":{"_yoast_wpseo_title":"Immunic hosted Multiple Sclerosis R&D Webcast, presenting updates on its lead asset, vidofludimus calcium - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","_yoast_wpseo_metadesc":"The company discussed the MS treatment landscape and recent scientific findings with key opinion leaders."},"permalink_migration":{"custom_uri":"izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunic hosted Multiple Sclerosis R&amp;D Webcast, presenting updates on its lead asset, vidofludimus calcium - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB<\/title>\n<meta name=\"description\" content=\"The company discussed the MS treatment landscape and recent scientific findings with key opinion leaders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunic hosted Multiple Sclerosis R&amp;D Webcast, presenting updates on its lead asset, vidofludimus calcium - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\" \/>\n<meta property=\"og:description\" content=\"The company discussed the MS treatment landscape and recent scientific findings with key opinion leaders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/\" \/>\n<meta property=\"og:site_name\" content=\"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-22T11:27:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/Immunic_Team.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"1098\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\\\/\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\\\/\",\"name\":\"Immunic hosted Multiple Sclerosis R&D Webcast, presenting updates on its lead asset, vidofludimus calcium - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Immunic_Team.jpg\",\"datePublished\":\"2022-11-23T21:32:18+00:00\",\"dateModified\":\"2026-07-22T11:27:19+00:00\",\"description\":\"The company discussed the MS treatment landscape and recent scientific findings with key opinion leaders.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#primaryimage\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Immunic_Team.jpg\",\"contentUrl\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Immunic_Team.jpg\",\"width\":2000,\"height\":1098,\"caption\":\"Das Immunic Management Team (v. li.): Dr. Andreas M\u00fchler (CMO), Dr. Hella Kohlhof (CSO) und Dr. Daniel Vitt (CEO & Pr\u00e4sident).\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/izb-biotech-news\\\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IZB Biotech News\",\"item\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/izb-biotech-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Immunic hosted Multiple Sclerosis R&#038;D Webcast, presenting updates on its lead asset, vidofludimus calcium\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/\",\"name\":\"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.\",\"description\":\"Der Ort f\u00fcr Biotech-Start-ups in M\u00fcnchen: Labore, B\u00fcror\u00e4ume, Netzwerk!\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/p664637.webspaceconfig.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunic hosted Multiple Sclerosis R&D Webcast, presenting updates on its lead asset, vidofludimus calcium - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","description":"The company discussed the MS treatment landscape and recent scientific findings with key opinion leaders.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/","og_locale":"en_US","og_type":"article","og_title":"Immunic hosted Multiple Sclerosis R&D Webcast, presenting updates on its lead asset, vidofludimus calcium - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","og_description":"The company discussed the MS treatment landscape and recent scientific findings with key opinion leaders.","og_url":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/","og_site_name":"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","article_modified_time":"2026-07-22T11:27:19+00:00","og_image":[{"width":2000,"height":1098,"url":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/Immunic_Team.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/","url":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/","name":"Immunic hosted Multiple Sclerosis R&D Webcast, presenting updates on its lead asset, vidofludimus calcium - Innovations- und Gr\u00fcnderzentrum Biotechnologie IZB","isPartOf":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/#primaryimage"},"image":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/#primaryimage"},"thumbnailUrl":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/Immunic_Team.jpg","datePublished":"2022-11-23T21:32:18+00:00","dateModified":"2026-07-22T11:27:19+00:00","description":"The company discussed the MS treatment landscape and recent scientific findings with key opinion leaders.","breadcrumb":{"@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/#primaryimage","url":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/Immunic_Team.jpg","contentUrl":"https:\/\/p664637.webspaceconfig.de\/wp-content\/uploads\/2026\/07\/Immunic_Team.jpg","width":2000,"height":1098,"caption":"Das Immunic Management Team (v. li.): Dr. Andreas M\u00fchler (CMO), Dr. Hella Kohlhof (CSO) und Dr. Daniel Vitt (CEO & Pr\u00e4sident)."},{"@type":"BreadcrumbList","@id":"https:\/\/p664637.webspaceconfig.de\/en\/izb-biotech-news\/immunic-hosted-multiple-sclerosis-rd-webcast-presenting-updates-on-its-lead-asset-vidofludimus-calcium-innovations-und-gruenderzentrum-biotechnologie-izb\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/p664637.webspaceconfig.de\/en\/"},{"@type":"ListItem","position":2,"name":"IZB Biotech News","item":"https:\/\/p664637.webspaceconfig.de\/izb-biotech-news\/"},{"@type":"ListItem","position":3,"name":"Immunic hosted Multiple Sclerosis R&#038;D Webcast, presenting updates on its lead asset, vidofludimus calcium"}]},{"@type":"WebSite","@id":"https:\/\/p664637.webspaceconfig.de\/en\/#website","url":"https:\/\/p664637.webspaceconfig.de\/en\/","name":"IZB Innovations- und Gr\u00fcnderzentrum Biotechnologie.","description":"Der Ort f\u00fcr Biotech-Start-ups in M\u00fcnchen: Labore, B\u00fcror\u00e4ume, Netzwerk!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/p664637.webspaceconfig.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/5991","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news"}],"about":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/types\/izb-biotech-news"}],"version-history":[{"count":1,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/5991\/revisions"}],"predecessor-version":[{"id":5993,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/izb-biotech-news\/5991\/revisions\/5993"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/media\/5989"}],"wp:attachment":[{"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/media?parent=5991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/categories?post=5991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/p664637.webspaceconfig.de\/en\/wp-json\/wp\/v2\/tags?post=5991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}